Black Diamond Therapeutics, Inc.·4

Jun 13, 7:09 PM ET

Mayweg Alexander 4

4 · Black Diamond Therapeutics, Inc. · Filed Jun 13, 2022

Insider Transaction Report

Form 4
Period: 2022-06-10
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-10+15,00015,000 total
    Exercise: $2.14Exp: 2032-06-09Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 7, 2023 or (ii) the Issuer's next annual meeting of stockholders.

Documents

1 file
  • 4
    form4-06132022_040616.xmlPrimary